Evergreen Theragnostics: Valuation, Funding & Investors
Evergreen Theragnostics develops theranostic solutions that integrate diagnostic technologies with targeted therapeutic strategies, aimed at enabling molecularly guided treatment selection and patient monitoring. The company focuses on providing actionable biomarker assays and companion diagnostics to support personalized medicine workflows for clinicians and clinical researchers.
Leadership & Board
- Current Number of Employees
- 55
- Current LinkedIn Followers
- 15,228
Latest Estimated Valuation
- Total Amount Raised
- $26M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $26M
- Latest Funding Round
- Series C
Employee Trend
Evergreen Theragnostics had 55 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Evergreen Theragnostics had 15,228 followers as of November 16, 2026. The number of followers increased by 3 (0.02%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| May 16, 2024 | Series C | $26.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| LIFTT | Series C |
| Petrichor Healthcare Capital Management | Series C |
Similar Companies
A snapshot of private companies similar to Evergreen Theragnostics, helping you discover and navigate related company profiles.






